Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00176_DB00315_nanopub.RAKWbyuBrQ9w8p04idEB8o5esCd8qsoF4411405j1oVwY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00176_DB00315 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00176_DB00315 label "DDI between Fluvoxamine and Zolmitriptan - Use of two serotonin modulators, such as zolmitriptan and fluvoxamine, may increase the risk of serotonin syndrome. Consider alternate therapy or monitor for serotonin syndrome during concomitant therapy. [drugbank_resource:DB00176_DB00315]" assertion.
- drugbank_resource:DB00176_DB00315 identifier "drugbank_resource:DB00176_DB00315" assertion.
- drugbank_resource:DB00176_DB00315 title "DDI between Fluvoxamine and Zolmitriptan - Use of two serotonin modulators, such as zolmitriptan and fluvoxamine, may increase the risk of serotonin syndrome. Consider alternate therapy or monitor for serotonin syndrome during concomitant therapy." assertion.
- drugbank:DB00176 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00176_DB00315 assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00176_DB00315 assertion.